ID   MONPSYi001-A-2
AC   CVCL_F0T1
SY   MONPSYi001-A-2-BTC-KO
DR   hPSCreg; MONPSYi001-A-2
RX   PubMed=40848400;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1121; BTC.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=40848400; DOI=10.1016/j.scr.2025.103808;
RA   Cota-Coronado, Agustin
RA   Manning, Murray
RA   Kim, Dong-Hyung
RA   Lee, Joohyung
RA   Gibbons, Andrew
RA   Rosenbluh, Joseph
RA   Hill, Rachel A.
RA   Sundram, Suresh
RT   "Generation of two betacellulin CRISPR-Cas9 knockout hiPSC lines to
RT   study the affected EGF system paradigm in schizophrenia.";
RL   Stem Cell Res. 88:103808-103808(2025).
//